BMJ15h
Synovitis detected on magnetic resonance imaging and its relation to pain and cartilage loss in knee osteoarthritis
Objective: To examine the relationship between longitudinal fluctuations in synovitis with change in pain and cartilage in knee osteoarthritis. Methods: Study subjects were patients 45 years of age ...
BMJ15d
The role of DNA in the pathogenesis of SLE: DNA as a molecular chameleon
Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease characterised by antibodies to DNA (anti-DNA) and other nuclear macromolecules. Anti-DNA antibodies are markers for classification ...
BMJ14d
Treatment of recalcitrant psoriasis and psoriatic arthritis with a combination of a biologic plus an oral JAK or TYK2 inhibitor: a case series
Correspondence to Dr Saakshi Khattri, Icahn School of Medicine at Mount Sinai, New York, New York, USA; saakshi.khattri{at}mountsinai.org If you wish to reuse any or ...
BMJ1d
Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study
3 Rheumatology Division, Geffen School of Medicine at the University of California–Los Angeles (UCLA), Los Angeles, CA, USA 4 Center for Innovative Therapy, University of California–San Diego, ...
BMJ1d
Smoking history, alcohol consumption, and systemic lupus erythematosus: a case-control study
Dr K R Muir, Division of Public Health Medicine and Epidemiology, School of Community Health Sciences, University Hospital, Queen’s Medical Centre, Nottingham, NG7 2UH. OBJECTIVE To investigate the ...
BMJ12d
Rheumatoid arthritis, treatment with corticosteroids and risk of malignant lymphomas: results from a case–control study
1 Rheumatology Unit, Department of Medicine, Karolinska Institutet at Karolinska University Hospital, Stockholm, Sweden 2 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, ...
BMJ6d
Development of a logically devised line drawing atlas for grading of knee osteoarthritis
Academic Rheumatology, University of Nottingham, Clinical Sciences Building, City Hospital, Nottingham NG5 1PB, UK RESULTS Intraobserver and interobserver reproducibility was similar and generally ...
BMJ4d
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies
Correspondence to Dr Sara Monti, Rheumatology, IRCCS Fondazione Policlinico S Matteo, Pavia 27100, Italy; sara.saramonti{at}gmail.com Different viral agents are associated with an increased risk of ...
BMJ12d
Prolonged treatment with Tadekinig alfa in adult-onset Still’s disease
Correspondence to Professor Cem Gabay, Division of Rheumatology,Department of Internal Medicine Specialties, University Hospitals of Geneva, Geneva 1211, Switzerland; cem.gabay{at}hcuge.ch Adult-onset ...
BMJ12d
Effectiveness of IL-12/23 inhibition (ustekinumab) versus tumour necrosis factor inhibition in psoriatic arthritis: observational PsABio study results
Objectives To evaluate 6-month effectiveness of ustekinumab versus tumour necrosis factor inhibitor (TNFi), analysing predictors of low disease activity (LDA)/remission. Methods PsABio is a ...
BMJ5d
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Correspondence to Dr Antonis Fanouriakis, Rheumatology and Clinical Immunology Unit, “Attikon” University Hospital, Athens 12462, Greece; afanour{at}med.uoa.gr Our objective was to update the EULAR ...
BMJ2d
Methotrexate in patients with moderate systemic lupus erythematosus (exclusion of renal and central nervous system disease)
a Medizinische Klinik und Poliklinik V, Universität Heidelberg, Germany , b St Vincenz und Elisabeth Hospital, Mainz, Germany Dr S Gansauge, St Vincenz und Elisabeth Hospital, Abteilung Rheumatologie, ...